Center for serological sciences network (seronet)
Active Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $79,896,408
Award facts
- Contract value 100% obligated
- $79,896,408.00 Current and potential, with all options
- Completion date 99% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$63,681,191 | |
| Terminate for Convenience | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $5,997,107 | |
| Change Order | $50,026,022 | |
| Exercise an Option | $1,885,950 | |
| Funding Only Action | -$882,865 | |
| Original award | $86,551,385 |
Show all 11
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on February 10, 2021, with a ceiling value of $79.9 million under a cost-plus-fixed-fee pricing structure, for the Center for Serological Sciences Network (SERONET) with an ultimate completion date of October 31, 2026.
Place of performance is Frederick, MD. Leidos Biomedical Research operates the Frederick National Laboratory for Cancer Research on behalf of NCI, with work also extending to subordinate NIH institutes and collaborative sites.
Service Contract Inventory reporting captures actual government-invoiced labor on this order across fiscal years 2021–2025. FY2025 (most recent) reflects 29.4 FTEs and 61,067 contractor hours at a derived government-paid hourly rate of $233.75/hr. The labor footprint expanded significantly from FY2021 (35.3 FTEs, $10.2 million invoiced) through FY2022 (62.2 FTEs, $20.2 million invoiced), then moderated to FY2024 levels (58.9 FTEs, $18 million invoiced) before stepping down in FY2025 (29.4 FTEs, $14.3 million invoiced). In FY2025, 12 subcontractors performed 44% of total contractor hours. Derived government-paid hourly rates have risen across the reporting period, reaching $233.75/hr in FY2025, reflecting the labor mix and inflation adjustments on the cost-plus structure.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on February 10, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $79,896,408 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award